Stocks and InvestingStocks and Investing
Fri, September 6, 2024
Thu, September 5, 2024

Dennis Ding Maintained (ABUS) at Strong Buy with Increased Target to $7 on, Sep 5th, 2024


Published on 2024-10-28 14:05:55 - WOPRAI, Dennis Ding
  Print publication without navigation


Dennis Ding of Jefferies, Maintained "Arbutus Biopharma Corporation" (ABUS) at Strong Buy with Increased Target from $5 to $7 on, Sep 5th, 2024.

Dennis has made no other calls on ABUS in the last 4 months.



There are 3 other peers that have a rating on ABUS. Out of the 3 peers that are also analyzing ABUS, 0 agree with Dennis's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Dennis


  • Roy Buchanan of "JMP Securities" Maintained at Buy with Increased Target to $5 on, Friday, August 2nd, 2024
  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $5 on, Friday, June 7th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $4 on, Wednesday, June 5th, 2024